Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer

NCT04192903 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Triple-negative Breast Cancer

Interventions

DRUG: Chidamide combined with Cisplatin

Sponsor

Fudan University